(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANTICORPOS MULTIESPECÍFICOS PARA O DIRECIONAMENTO A CD28 E PD-L1 E MÉTODOS DE USO DESTES

Em AnáliseInvention PatentPCT · US2021057384

Application data

Number

112023008016

Type

Invention Patent

Filing

10/29/2021

Publication

07/04/2023

PCT

US2021057384

Progress at the INPI

  1. Filing10/29/21
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 10/29/2021. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 07/04/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

JANUX THERAPEUTICS, INC.

US

Inventors

D. C. (pessoa física)

US

T. D. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

63/107,942 · 10/30/2020

US

63/123,327 · 12/09/2020

US

63/123,329 · 12/09/2020

US

63/141,268 · 01/25/2021

US

63/187,690 · 05/12/2021

US

63/187,699 · 05/12/2021

US

63/187,719 · 05/12/2021

US

63/189,843 · 05/18/2021

Abstract

ANTICORPOS MULTIESPECÍFICOS PARA O DIRECIONAMENTO A CD28 E PD-L1 E MÉTODOS DE USO DESTES. São fornecidos nesse relatório descritivo anticorpos que se ligam seletivamente a CD28 e PD-L1, composições farmacêuticas destes, bem como ácidos nucleicos, e métodos de uso, e métodos para a produção e descoberta dos mesmos.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

07/04/2023

RPI 2739

Alteração de dados cadastrais

#1.1

05/09/2023

RPI 2731

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.